Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection

This publication has 30 references indexed in Scilit:

• A Randomized Study of the Effects of Adenine Arabinoside 5′–Monophosphate (Short or Long Courses) and Lymphoblastoid Interferon on Hepatitis B Virus Replication
  Hepatology, 1985
• Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
  Gut, 1985
• Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication
  Liver International, 1984
• Acute Dane Particle Suppression with Recombinant Leukocyte A Interferon in Chronic Hepatitis B Virus Infection
  The Journal of Infectious Diseases, 1983
• Acyclovir in hepatitis B antigen—positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration
  Journal of Antimicrobial Chemotherapy, 1983
• Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
  Gut, 1982
• Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination
  Antimicrobial Agents and Chemotherapy, 1982
• NATURAL HISTORY OF LIVER DISEASE IN CHRONIC HEPATITIS B SURFACE ANTIGEN CARRIERS
  The Lancet, 1981
• Adenine arabinoside therapy in HBsAg-positive chronic liver disease: A controlled study
  Gastroenterology, 1981
• Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active Hepatitis
  New England Journal of Medicine, 1976